Harte Hanks Inc (HHS) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Harte Hanks Inc stock (HHS) is currently trading at $2.43. Harte Hanks Inc PS ratio (Price-to-Sales) is 0.12. Analyst consensus price target for HHS is $17.50. WallStSmart rates HHS as Sell.
- HHS PE ratio analysis and historical PE chart
- HHS PS ratio (Price-to-Sales) history and trend
- HHS intrinsic value — DCF, Graham Number, EPV models
- HHS stock price prediction 2025 2026 2027 2028 2029 2030
- HHS fair value vs current price
- HHS insider transactions and insider buying
- Is HHS undervalued or overvalued?
- Harte Hanks Inc financial analysis — revenue, earnings, cash flow
- HHS Piotroski F-Score and Altman Z-Score
- HHS analyst price target and Smart Rating
Harte Hanks Inc
📊 No data available
Try selecting a different time range
Smart Analysis
Harte Hanks Inc (HHS) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, price/sales, price/book. Concerns around market cap and return on equity. Mixed signals suggest waiting for clearer direction before acting.
Harte Hanks Inc (HHS) Key Strengths (3)
Paying less than $1 for every $1 of annual revenue
Trading below book value, meaning the market prices it less than net assets
Good growth relative to its price
Supporting Valuation Data
Harte Hanks Inc (HHS) Areas to Watch (7)
Company is destroying shareholder value
Revenue declining -17.00%, a shrinking business
Earnings declining -90.30%, profits shrinking
Company is losing money with a negative profit margin
Near-zero operating margins, business under pressure
Micro-cap company with very limited liquidity and high volatility
Moderate institutional interest at 31.45%
Harte Hanks Inc (HHS) Detailed Analysis Report
Overall Assessment
This company scores 41/100 in our Smart Analysis, earning a D grade. Out of 10 metrics analyzed, 3 register as strengths (avg 9.3/10) while 7 fall into concern territory (avg 1.4/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book, PEG Ratio. Valuation metrics including PEG Ratio (1.19), Price/Sales (0.12), Price/Book (0.89) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Revenue Growth, EPS Growth. Growth concerns include Revenue Growth at -17.00%, EPS Growth at -90.30%, which may limit upside. Profitability pressure is visible in Return on Equity at -26.60%, Operating Margin at 2.65%, Profit Margin at -3.27%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -26.60% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -17.00% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Revenue Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
HHS Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
HHS's Price-to-Sales ratio of 0.12x trades at a 28% premium to its historical average of 0.09x (77th percentile). The current valuation is 45% below its historical high of 0.21x set in Jun 2018, and 475% above its historical low of 0.02x in May 2016.
WallStSmart Analysis Synopsis
Data-driven financial summary for Harte Hanks Inc (HHS) · INDUSTRIALS › CONGLOMERATES
The Big Picture
Harte Hanks Inc is in a turnaround phase, with management focused on restoring profitability. Revenue reached 167M with 17% decline year-over-year. The company is currently unprofitable, posting a -3.3% profit margin.
Key Findings
Revenue contracted 17% YoY. Worth determining whether this is cyclical or structural.
The company is unprofitable with a -3.3% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Debt management: total debt of 22M is significantly higher than cash (7M). Monitor refinancing risk.
Sector dynamics: monitor CONGLOMERATES industry trends, competitive moves, and regulatory changes that could impact Harte Hanks Inc.
Bottom Line
Harte Hanks Inc is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(0 last 3 months)
Data sourced from SEC Form 4 filings
Last updated: 2:28:54 PM
About Harte Hanks Inc(HHS)
NASDAQ
INDUSTRIALS
CONGLOMERATES
USA
Harte Hanks, Inc. is a customer experience company in the United States and internationally. The company is headquartered in Chelmsford, Massachusetts.